CIK 0001754068
- Non-accelerated filer
- Smaller reporting company
Kalaris Therapeutics, Inc.
Sign in to watch- Ticker
- KLRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831971007
- Phone
- +1 650-249-2727
- Business address
- 400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Allovir, Inc., ViraCyte, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 25 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-17 | Brenner Malcolm Director | Sale | −200 | $41.99 | $8K | 1,007,278 |
| 2021-02-17 | Leen Ann M. Chief Scientific Officer | Sale | −500 | $38.63 | $19K | 2,493,617 |
| 2021-02-17 | Leen Ann M. Chief Scientific Officer | Sale | −400 | $39.85 | $16K | 2,493,217 |
| 2021-02-17 | Leen Ann M. Chief Scientific Officer | Sale | −1,386 | $41.28 | $57K | 2,491,831 |
| 2021-02-17 | VAN BEEK JEROEN B Chief Commercial Officer | Sale | −500 | $38.42 | $19K | 507,130 |
| 2021-02-17 | VAN BEEK JEROEN B Chief Commercial Officer | Sale | −400 | $39.72 | $16K | 506,730 |
| 2021-02-17 | VAN BEEK JEROEN B Chief Commercial Officer | Sale | −1,300 | $41.22 | $54K | 505,430 |
| 2021-02-17 | VAN BEEK JEROEN B Chief Commercial Officer | Sale | −100 | $41.56 | $4K | 505,330 |
| 2021-02-17 | Hagen Brett R Chief Accounting Officer | Sale | −600 | $38.56 | $23K | 68,026 |
| 2021-02-17 | Hagen Brett R Chief Accounting Officer | Sale | −220 | $39.86 | $9K | 67,806 |
| 2021-02-17 | Hagen Brett R Chief Accounting Officer | Sale | −1,300 | $41.17 | $54K | 66,506 |
| 2021-02-17 | Hagen Brett R Chief Accounting Officer | Sale | −200 | $41.68 | $8K | 66,306 |
| 2021-02-16 | Vera Juan Director | Sale | −9,434 | $41.79 | $394K | 2,457,536 |
| 2021-02-16 | Vera Juan Director | Sale | −966 | $42.53 | $41K | 2,456,570 |
| 2021-02-16 | Brenner Malcolm Director | Sale | −5,120 | $41.75 | $214K | 1,013,543 |
| 2021-02-16 | Brenner Malcolm Director | Sale | −1,000 | $42.25 | $42K | 1,012,543 |
| 2021-02-16 | Brenner Malcolm Director | Sale | −100 | $43.13 | $4K | 1,012,443 |
| 2021-02-16 | Leen Ann M. Chief Scientific Officer | Sale | −2,850 | $41.82 | $119K | 2,494,317 |
| 2021-02-16 | Leen Ann M. Chief Scientific Officer | Sale | −200 | $42.79 | $9K | 2,494,117 |
| 2021-02-16 | VAN BEEK JEROEN B Chief Commercial Officer | Sale | −2,700 | $41.76 | $113K | 508,030 |
Page 24 of 27 · 527 trades